These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32133997)

  • 1. Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization.
    Mitropoulou AN; Ceska T; Heads JT; Beavil AJ; Henry AJ; McDonnell JM; Sutton BJ; Davies AM
    Acta Crystallogr F Struct Biol Commun; 2020 Mar; 76(Pt 3):116-129. PubMed ID: 32133997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the omalizumab Fab.
    Jensen RK; Plum M; Tjerrild L; Jakob T; Spillner E; Andersen GR
    Acta Crystallogr F Struct Biol Commun; 2015 Apr; 71(Pt 4):419-26. PubMed ID: 25849503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab.
    Davies AM; Allan EG; Keeble AH; Delgado J; Cossins BP; Mitropoulou AN; Pang MOY; Ceska T; Beavil AJ; Craggs G; Westwood M; Henry AJ; McDonnell JM; Sutton BJ
    J Biol Chem; 2017 Jun; 292(24):9975-9987. PubMed ID: 28438838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody.
    Chen JB; Ramadani F; Pang MOY; Beavil RL; Holdom MD; Mitropoulou AN; Beavil AJ; Gould HJ; Chang TW; Sutton BJ; McDonnell JM; Davies AM
    Sci Rep; 2018 Aug; 8(1):11548. PubMed ID: 30069035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and Physical Basis for Anti-IgE Therapy.
    Wright JD; Chu HM; Huang CH; Ma C; Chang TW; Lim C
    Sci Rep; 2015 Jun; 5():11581. PubMed ID: 26113483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluorescent biosensor reveals conformational changes in human immunoglobulin E Fc: implications for mechanisms of receptor binding, inhibition, and allergen recognition.
    Hunt J; Keeble AH; Dale RE; Corbett MK; Beavil RL; Levitt J; Swann MJ; Suhling K; Ameer-Beg S; Sutton BJ; Beavil AJ
    J Biol Chem; 2012 May; 287(21):17459-17470. PubMed ID: 22442150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction.
    Jabs F; Plum M; Laursen NS; Jensen RK; Mølgaard B; Miehe M; Mandolesi M; Rauber MM; Pfützner W; Jakob T; Möbs C; Andersen GR; Spillner E
    Nat Commun; 2018 Jan; 9(1):7. PubMed ID: 29295972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.
    Pennington LF; Tarchevskaya S; Brigger D; Sathiyamoorthy K; Graham MT; Nadeau KC; Eggel A; Jardetzky TS
    Nat Commun; 2016 May; 7():11610. PubMed ID: 27194387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric inhibition of IgE-FcεRI interactions by simultaneous targeting of IgE F(ab')2 epitopes.
    Hirano T; Koyanagi A; Ago H; Yamamoto M; Kitaura J; Kasai M; Okumura K
    Commun Biol; 2024 Aug; 7(1):1042. PubMed ID: 39179708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to FcεRIα Suppresses Immunoglobulin E Binding to High-Affinity Receptor I in Allergic Inflammation.
    Hong JY; Bae JH; Lee KE; Kim M; Kim MH; Kang HJ; Park EH; Yoo KS; Jeong SK; Kim KW; Kim KE; Sohn MH
    Yonsei Med J; 2016 Nov; 57(6):1412-9. PubMed ID: 27593869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.
    Eggel A; Baravalle G; Hobi G; Kim B; Buschor P; Forrer P; Shin JS; Vogel M; Stadler BM; Dahinden CA; Jardetzky TS
    J Allergy Clin Immunol; 2014 Jun; 133(6):1709-19.e8. PubMed ID: 24642143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulated immune complexes of IgE and omalizumab trap allergens in an in vitro model.
    Hsu CL; Shiung YY; Lin BL; Chang HY; Chang TW
    Int Immunopharmacol; 2010 Apr; 10(4):533-9. PubMed ID: 20139035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the mimicry of polysaccharide antigens by anti-idiotypic antibodies. The crystallization, molecular replacement, and refinement to 2.8 A resolution of an idiotope-anti-idiotope Fab complex and of the unliganded anti-idiotope Fab.
    Evans SV; Rose DR; To R; Young NM; Bundle DR
    J Mol Biol; 1994 Sep; 241(5):691-705. PubMed ID: 8071993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca2+-dependent structural changes in the B-cell receptor CD23 increase its affinity for human immunoglobulin E.
    Yuan D; Keeble AH; Hibbert RG; Fabiane S; Gould HJ; McDonnell JM; Beavil AJ; Sutton BJ; Dhaliwal B
    J Biol Chem; 2013 Jul; 288(30):21667-77. PubMed ID: 23775083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.
    Mirkina I; Schweighoffer T; Kricek F
    Immunol Lett; 2007 Apr; 109(2):120-8. PubMed ID: 17368811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the antigen-independent cytokinergic SPE-7 IgE activation of human mast cells in vitro.
    Bax HJ; Bowen H; Dodev TS; Sutton BJ; Gould HJ
    Sci Rep; 2015 Apr; 5():9538. PubMed ID: 25892150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
    Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
    Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the human IgE-Fc C epsilon 3-C epsilon 4 reveals conformational flexibility in the antibody effector domains.
    Wurzburg BA; Garman SC; Jardetzky TS
    Immunity; 2000 Sep; 13(3):375-85. PubMed ID: 11021535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
    Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
    J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of IgE-dependent histamine release from human peripheral blood basophils by humanized Fab fragments that recognize the membrane proximal domain of the human Fc epsilon RI alpha-chain.
    Takai T; Yuuki T; Ra C
    Int Arch Allergy Immunol; 2000 Dec; 123(4):308-18. PubMed ID: 11146388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.